Literature DB >> 2114554

The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation.

B Wasylyk1, C Wasylyk, P Flores, A Begue, D Leprince, D Stehelin.   

Abstract

Cell transformation by oncogenes leads to changes in gene expression. A key event in this process seems to be activation of the transcription factors AP-1 and PEA 3. Their synergistic activities are required for efficient activation of transcription from different promoters by many different oncogenes, serum growth factors and the tumour promoter TPA. We show here that the products of the ets-1 and -2 proto-oncogenes, whose biological function was previously unknown, are transcription factors that activate transcription through the PEA 3 motif. The p68c-ets-1 protein specifically binds to DNA and contains a transcriptional activation domain. The ets-like gene family therefore seems to encode a new family of transcription factors, apparently unrelated to other transcription factors. The p68c-ets-1 protein cooperates with c-Fos and c-Jun (components of AP-1) for activation of transcription from the oncogene-responsive domain of the polyoma enhancer, indicating that combined activity of all three oncoproteins could be involved in the response of cells to growth stimuli.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2114554     DOI: 10.1038/346191a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  154 in total

1.  The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering.

Authors:  D Tulasne; R Paumelle; K M Weidner; B Vandenbunder; V Fafeur
Journal:  Mol Biol Cell       Date:  1999-03       Impact factor: 4.138

2.  Sequential activation of ERK and repression of JNK by scatter factor/hepatocyte growth factor in madin-darby canine kidney epithelial cells.

Authors:  R Paumelle; D Tulasne; C Leroy; J Coll; B Vandenbunder; V Fafeur
Journal:  Mol Biol Cell       Date:  2000-11       Impact factor: 4.138

3.  Kinetic analysis of the steps of the polyomavirus lytic cycle.

Authors:  L Chen; M Fluck
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

Review 4.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

5.  Methylation of an ETS site in the intron enhancer of the keratin 18 gene participates in tissue-specific repression.

Authors:  A Umezawa; H Yamamoto; K Rhodes; M J Klemsz; R A Maki; R G Oshima
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

6.  c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans.

Authors:  N Wernert; M B Raes; P Lassalle; M P Dehouck; B Gosselin; B Vandenbunder; D Stehelin
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

7.  Different binding site requirements for binding and activation for the bipartite enhancer factor EF-1A.

Authors:  G M Bolwig; J T Bruder; P Hearing
Journal:  Nucleic Acids Res       Date:  1992-12-25       Impact factor: 16.971

8.  An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene.

Authors:  J Hagman; R Grosschedl
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

9.  A positive regulator of the ribosomal protein gene, beta factor, belongs to the ETS oncoprotein family.

Authors:  T Yoganathan; N K Bhat; B H Sells
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

10.  The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation.

Authors:  I Kola; S Brookes; A R Green; R Garber; M Tymms; T S Papas; A Seth
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.